Literature DB >> 724294

Splenic sequestration and ineffective erythropoiesis in hemoglobin E-beta-thalassemia disease.

F B Ruymann, L A Popejoy, R B Brouillard.   

Abstract

A 13-year-old Thai female with hemoglobin E-beta-thalassemia was evaluated for anemia and splenomegaly. Globin chain synthesis in a whole cell system revealed an absence of betaA chains and excessive alpha chains. The alpha/betaE + gamma ratio was 1.26 in bone marrow and 1.90 in peripheral blood. The average gamma/betaE ratio in bone marrow and peripheral blood was 0.36 compared to peripheral blood concentrations of 49% hemoglobin E and 51% hemoglobin F. Homologous red cell 51Cr half-life increased from 22.7 days to 32.8 days after splenectomy. Total circulating hemoglobin increased from 112.9 to 149.7 g. Endogenous carbon monoxide productive (Vco) as a measure of total heme catabolism decreased from 2.00 to 1.54 mumol/hr/kg. Ineffective erythropoiesis was manifested by an increased Vco/Vheme-c ratio of 7.52.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 724294     DOI: 10.1203/00006450-197810000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Inhibition of erythrocyte "apoptosis" by catecholamines.

Authors:  Philipp A Lang; Daniela S Kempe; Ahmad Akel; Barbara A Klarl; Kerstin Eisele; Marlies Podolski; Tobias Hermle; Olivier M Niemoeller; Philipp Attanasio; Stephan M Huber; Thomas Wieder; Florian Lang; Christophe Duranton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-25       Impact factor: 3.000

2.  Thrombo-embolic complications after splenectomy in HbE-beta-thalassaemia.

Authors:  F A Wijburg; W van den Berg; A van Teunenbroek; R S Weening
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

3.  Molecular analysis of the beta-thalassemia phenotype associated with inheritance of hemoglobin E (alpha 2 beta2(26)Glu leads to Lys).

Authors:  E J Benz; B W Berman; B L Tonkonow; E Coupal; T Coates; L A Boxer; A Altman; J G Adams
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.